US-Guided FNA for Salivary Gland Masses

Reference Images

US-guided FNA indications for salivary gland masses
FNA IndicationsClick to enlarge
Salivary lesion type and recommended next step
Next Step TableClick to enlarge
When salivary FNA may not be necessary
When FNA May Be SkippedClick to enlarge
FNA versus core needle biopsy in salivary masses
FNA vs CNBClick to enlarge
US-guided FNA protocol summary for salivary masses
Protocol SummaryClick to enlarge

FNA Indications

Core rule Any focal salivary incidentaloma should be assessed with ultrasound. Solid or solid-dominant salivary incidentalomas generally require US-guided FNA cytology.

Recommend US-guided FNA when

  • Solid or solid-dominant salivary lesion.
  • Indeterminate CT, MRI, PET, or ultrasound appearance.
  • Diagnosis will alter treatment, surgery, or follow-up.
  • Cystic lesion is symptomatic, enlarging, thick-walled, has mural nodularity, or has a solid component.
  • Suspicious intraparotid or cervical lymph node can be sampled during the same ultrasound-guided session.
Macro: Solid or indeterminate salivary mass - targeted ultrasound plus US-guided FNA for Milan System cytology classification.

When FNA May Not Be Needed

Often observe / no biopsy

  • Classic intraparotid lymph node: small, oval, homogeneous, fatty hilum or classic nodal appearance, and no suspicious clinical context.
  • Tiny simple cyst: thin wall, no solid component, no mural nodule, and no wall thickening.
  • Known benign stable lesion: prior benign FNA or histology, stable imaging appearance, no growth, and no new symptoms.
  • Repeat FNA is usually reserved for interval growth or a change in clinical/imaging concern.

Do not skip FNA if

  • Solid component, mural nodule, infiltrative margin, suspicious nodes, growth, symptoms, or malignancy context.
  • Cystic lesion is symptomatic, enlarging, thick-walled, or concerning for cystic neoplasm.

FNA vs CNB

FNA first-line

  • First-line for most solid salivary masses.
  • Minimally invasive and widely used for benign versus malignant triage.
  • Supports Milan System cytology category and risk stratification.
  • Can sample suspicious adjacent intraparotid or cervical lymph nodes.

Add or prefer CNB when

  • Suspected lymphoma or need for tissue architecture.
  • Repeated nondiagnostic or equivocal FNA.
  • High-grade or anaplastic concern.
  • Definitive pre-operative histology is important for management.

Sources

Secondary Links